The interaction of versican with its binding partners

Cell Research

Volumn 15, Issue 7, 2005, Pages 483-494

  Wu, Yao Jiong ^a,c   La Pierre, David P ^a,c   Wu, Jin ^b   Yee, Albert J ^a   Yang, Burton B ^a,c  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Extracellular matrix; G3 domain; Glycosaminoglycan; Interaction; Proteoglycan

Indexed keywords

CSPG2 PROTEIN, HUMAN; LECTIN; MEMBRANE PROTEIN; PROTEOCHONDROITIN SULFATE; VERSICAN;

ANIMAL; CHEMISTRY; EXTRACELLULAR MATRIX; HUMAN; METABOLISM; PROTEIN BINDING; REVIEW;

ANIMALS; EXTRACELLULAR MATRIX; HUMANS; LECTINS, C-TYPE; MEMBRANE PROTEINS; PROTEIN BINDING; PROTEOCHONDROITIN SULFATES; VERSICANS;

EID: 27244432621     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cr.7290318     Document Type: Review

References (106)

1. Kimata K, Oike Y, Tani K, et al. A large chondroitin sulfate proteoglycan (PG-M) synthesized before chondrogenesis in the limb bud of chick embryo. J Biol Chem 1986; 261:13517-25.
2. Shinomura T, Nishida Y, Ito K, et al. cDNA cloning of PG-M, a large chondroitin sulfate proteoglycan expressed during chondrogenesis in chick limb buds. Alternative spliced multiforms of PG-M and their relationships to versican. J Biol Chem 1993; 268:14461-9.
3. Zimmermann DR, Ruoslahti E. Multiple domains of the large fibroblast proteoglycan, versican. EMBO J 1989; 8:2975-81.
4. Kiani C, Chen L, Wu YJ, et al. Structure and function of aggrecan. Cell Res 2002; 12:19-32.
5. Li H, Schwartz NB, Vertel BM. cDNA cloning of chick cartilage chondroitin sulfate (aggrecan) core protein and identification of a stop codon in the aggrecan gene associated with the chondrodystrophy, nanomelia. J Biol Chem 1993; 268:23504-11.
6. Rauch U, Karthikeyan L, Maurel P, et al. Cloning and primary structure of neurocan, a developmentally regulated, aggregating chondroitin sulfate proteoglycan of brain. J Biol Chem 1992; 267:19536-47.
7. Yamada H, Watanabe K, Shimonaka M, et al. Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family. J Biol Chem 1994; 269:10119-26.
8. Wu Y, Zhang Y, Cao L, et al. Identification of the motif in versican G3 domain that plays a dominant-negative effect on astrocytoma cell proliferation through inhibiting versican secretion and binding. J Biol Chem 2001; 276:14178-86.
9. Zhang Y, Cao L, Kiani CG, et al. The G3 domain of versican inhibits mesenchymal chondrogenesis via the epidermal growth factor-like motifs. J Biol Chem 1998; 273:33054-63.
10. Zhang Y, Wu Y, Cao L, et al. Versican modulates embryonic chondrocyte morphology via the epidermal growth factor-like motifs in G3. Exp Cell Res 2001; 263:33-42.
11. Zhang Y, Cao L, Yang BL, et al. The G3 domain of versican enhances cell proliferation via epidermial growth factor-like motifs. J Biol Chem 1998; 273:21342-51.
12. Spivak-Kroizman T, Lemmon MA, Dikic I, et al. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 1994; 79:1015-24.
13. Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 1991; 64:867-9.
14. Tanaka Y, Adams DH, Shaw S. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today 1993; 14:111-5.
15. Bandtlow CE, Zimmermann DR. Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol Rev 2000; 80:1267-90.
16. Retzler C, Wiedemann H, Kulbe G, et al. Structural and electron microscopic analysis of neurocan and recombinant neurocan fragments. J Biol Chem 1996; 271:17107-13.
17. Aspberg A, Miura R, Bourdoulous S, et al. The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety. Proc Natl Acad Sci U S A 1997; 94:10116-21.
18. Ang LC, Zhang Y, Cao L, et al. Versican enhances locomotion of astrocytoma cells and reduces cell adhesion through its G1 domain. J Neuropathol Exp Neurol 1999; 58:597-605.
19. Chen L, Yang BL, Wu Y, et al. G3 domains of aggrecan and PG-M/versican form intermolecular disulfide bonds that stabilize cell-matrix interaction. Biochemistry 2003; 42:8332-41.
20. Yang BL, Cao L, Kiani C, et al. Tandem repeats are involved in G1 domain inhibition of versican expression and secretion and the G3 domain enhances glycosaminoglycan modification and product secretion via the complement-binding protein-like motif. J Biol Chem 2000; 275:21255-61.
21. Yang BL, Yang BB, Erwin M, et al. Versican G3 domain enhances cellular adhesion and proliferation of bovine intervertebral disc cells cultured in vitro. Life Sci 2003; 73:3399-413.
22. Zhang Y, Cao L, Kiani C, et al. Promotion of chondrocyte proliferation by versican mediated by G1 domain and EGF-like motifs. J Cell Biochem 1999; 73:445-57.
23. Iozzo RV, Naso MF, Cannizzaro LA, et al. Mapping of the versican proteoglycan gene (CSPG2) to the long arm of human chromosome 5 (5q12-5q14). Genomics 1992; 14:845-51.
24. Naso MF, Zimmermann DR, Iozzo RV. Characterization of the complete genomic structure of the human versican gene and functional analysis of its promoter. J Biol Chem 1994; 269:32999-3008.
25. McEver RP. Selectins. Curr Opin Immunol 1994; 6:75-84.
26. Dours-Zimmermann MT, Zimmermann DR. A novel glycosaminoglycan attachment domain identified in two alternative splice variants of human versican. J Biol Chem 1994; 269:32992-8.
27. Ito K, Shinomura T, Zako M, et al. Multiple forms of mouse PG-M, a large chondroitin sulfate proteoglycan generated by alternative splicing. J Biol Chem 1995; 270:958-65.
28. Zako M, Shinomura T, Ujita M, et al. Expression of PG-M(V3), an alternatively spliced form of PG-M without a chondroitin sulfate attachment in region in mouse and human tissues. J Biol Chem 1995; 270:3914-8.
29. Chen L, Wu Y, Lee V, et al. The folded modules of aggrecan G3 domain exert two separable functions in glycosaminoglycan modification and product secretion. J Biol Chem 2002; 277: 2657-65.
30. Kiani C, Lee V, Cao L, et al. Roles of aggrecan domains in biosynthesis, modification by glycosaminoglycans and product secretion. Biochem J 2001; 354:199-207.
31. Kiani C, Chen L, Lee V, et al. Identification of the motifs and amino acids in aggrecan G1 and G2 domains involved in product secretion. Biochemistry 2003; 42:7226-37.
32. Kitagawa H, Tsutsumi K, Tone Y, et al. Developmental regulation of the sulfation profile of chondroitin sulfate chains in the chicken embryo brain. J Biol Chem 1997; 272:31377-81.
33. Laurent TC, Fraser JR. Hyaluronan. FASEB J 1992; 6:2397-404.
34. Toole BP. Hyaluronan and its binding proteins, the hyaladherins. Curr Opin Cell Biol 1990; 2:839-44.
35. Bartolazzi A, Peach R, Aruffo A, et al. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 1994; 180:53-66.
36. Toole BP. Hyaluronan promotes the malignant phenotype. Glycobiology 2002; 12:37R-42R.
37. Itano N, Atsumi F, Sawai T, et al. Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration. Proc Natl Acad Sci U S A 2002; 99:3609-14.
38. Culty M, Nguyen HA, Underhill CB. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol 1992; 116:1055-62.
39. Lee JY, Spicer AP. Hyaluronan: a multifunctional, megaDalton, stealth molecule. Curr Opin Cell Biol 2000; 12:581-6.
40. Bourguignon LY, Zhu H, Shao L, et al. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. Cell Motil Cytoskeleton 1999; 43:269-87.
41. Oliferenko S, Kaverina I, Small JV, et al. Hyaluronic acid (HA) binding to CD44 activates Rac1 and induces lamellipodia outgrowth. J Cell Biol 2000; 148:1159-64.
42. Zhu D, Bourguignon LY. Interaction between CD44 and the repeat domain of ankyrin promotes hyaluronic acid-mediated ovarian tumor cell migration. J Cell Physiol 2000; 183:182-95.
43. Bourguignon LY, Zhu H, Chu A, et al. Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J Biol Chem 1997; 272:27913-8.
44. Ilangumaran S, Briol A, Hoessli DC. CD44 selectively associates with active Src family protein tyrosine kinases Lck and Fyn in glycosphingolipid-rich plasma membrane domains of human peripheral blood lymphocytes. Blood 1998; 91:3901-8.
45. Fitzgerald KA, Bowie AG, Skeffington BS, et al. Ras, protein kinase C zeta, and I kappa B kinases 1 and 2 are downstream effectors of CD44 during the activation of NF-kappa B by hyaluronic acid fragments in T-24 carcinoma cells. J Immunol 2000; 164:2053-63.
46. Noble PW, McKee CM, Cowman M, et al. Hyaluronan fragments activate an NF-kappa B/I-kappa B alpha autoregulatory loop in murine macrophages. J Exp Med 1996; 183:2373-8.
47. Koochekpour S, Pilkington GJ, Merzak A. Hyaluronic acid/CD44H interaction induces cell detachment and stimulates migration and invasion of human glioma cells in vitro. Int J Cancer 1995; 63:450-4.
48. Yamagata M, Saga S, Kato M, et al. Selective distributions of proteoglycans and their ligands in pericellular matrix of cultured fibroblasts. Implications for their roles in cell-substratum adhesion. J Cell Sci 1993; 106 (Pt 1):55-65.
49. Karvinen S, Kosma VM, Tammi MI, et al. Hyaluronan, CD44 and versican in epidermal keratinocyte tumours. Br J Dermatol 2003; 148:86-94.
50. Matsumoto K, Shionyu M, Go M, et al. Distinct interaction of versican/PG-M with hyaluronan and link protein. J Biol Chem 2003; 278:41205-12.
51. Yang BL, Zhang Y, Cao L, et al. Cell adhesion and proliferation mediated through the G1 domain of versican. J Cell Biochem 1999; 72:210-20.
52. Kawashima H, Hirose M, Hirose J, et al. Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44. J Biol Chem 2000; 275:35448-56.
53. Grumet M, Milev P, Sakurai T, et al. Interactions with tenascin and differential effects on cell adhesion of neurocan and phosphacan, two major chondroitin sulfate proteoglycans of nervous tissue. J Biol Chem 1994; 269:12142-6.
54. Salmivirta M, Elenius K, Vainio S, et al. Syndecan from embryonic tooth mesenchyme binds tenascin. J Biol Chem 1991; 266: 7733-39.
55. Erickson HP. Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. Curr Opin Cell Biol 1993; 5:869-76.
56. Hagios C, Koch M, Spring J, et al. Tenascin-Y: a protein of novel domain structure is secreted by differentiated fibroblasts of muscle connective tissue. J Cell Biol 1996; 134:1499-512.
57. Weber P, Bartsch U, Rasband MN, et al. Mice deficient for tenascin-R display alterations of the extracellular matrix and decreased axonal conduction velocities in the CNS. J Neurosci 1999; 19:4245-62.
58. Margolis RU, Margolis RK. Chondroitin sulfate proteoglycans as mediators of axon growth and pathfinding. Cell Tissue Res 1997; 290:343-8.
59. Pesheva P, Probstmeier R, Spiess E, et al. Divalent Cations Modulate the Inhibitory Substrate Properties of Murine Glia-derived J1-160 and J1-180 Extracellular Matrix Glycoproteins for Neuronal Adhesion. Eur J Neurosci 1991; 3:356-65.
60. Yamaguchi Y. Lecticans: organizers of the brain extracellular matrix. Cell Mol Life Sci 2000; 57:276-89.
61. Forsberg E, Hirsch E, Frohlich L, et al. Skin wounds and severed nerves heal normally in mice lacking tenascin-C. Proc Natl Acad Sci U S A 1996; 93:6594-9.
62. Timpl R, Sasaki T, Kostka G, et al. Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol 2003; 4:479-89.
63. Olin AI, Morgelin M, Sasaki T, et al. The proteoglycans aggrecan and Versican form networks with fibulin-2 through their lectin domain binding. J Biol Chem 2001; 276:1253-61.
64. Isogai Z, Aspberg A, Keene DR, et al. Versican interacts with fibrillin-1 and links extracellular microfibrils to other connective tissue networks. J Biol Chem 2002; 277:4565-72.
65. Aspberg A, Adam S, Kostka G, et al. Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican. J Biol Chem 1999; 274:20444-9.
66. Wight T. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 2002; 14:617.
67. Yamagata M, Yamada KM, Yoneda M, et al. Chondroitin sulfate proteoglycan (PG-M-like proteoglycan) is involved in the binding of hyaluronic acid to cellular fibronectin. J Biol Chem 1986; 261:13526-35.
68. Touab M, Villena J, Barranco C, et al. Versican is differentially expressed in human melanoma and may play a role in tumor development. Am J Pathol 2002; 160:549-57.
69. Braunewell KH, Pesheva P, McCarthy JB, et al. Functional involvement of sciatic nerve-derived versican- and decorin-like molecules and other chondroitin sulphate proteoglycans in ECM-mediated cell adhesion and neurite outgrowth. Eur J Neurosci 1995; 7:805-14.
70. Sakko AJ, Ricciardelli C, Mayne K, et al. Modulation of prostate cancer cell attachment to matrix by versican. Cancer Res 2003; 63:4786-91.
71. Zheng PS, Wen J, Ang LC, et al. Versican/PG-M G3 domain promotes tumor growth and angiogenesis. FASEB J 2004; 18:754-6.
72. Wijelath ES, Murray J, Rahman S, et al. Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ Res 2002; 91:25-31.
73. Kawashima H, Atarashi K, Hirose M, et al. Oversulfated chondroitin/dermatan sulfates containing GlcAbeta1/IdoAalpha1-3GalNAc(4,6-O- disulfate) interact with L- and P-selectin and chemokines. J Biol Chem 2002; 277:12921-30.
74. Hirose J, Kawashima H, Yoshie O, et al. Versican interacts with chemokines and modulates cellular responses. J Biol Chem 2001; 276:5228-34.
75. Pachynski RK, Wu SW, Gunn MD, et al. Secondary lymphoid-tissue chemokine (SLC) stimulates integrin alpha 4 beta 7-mediated adhesion of lymphocytes to mucosal addressin cell adhesion molecule-1 (MAdCAM-1) under flow. J Immunol 1998; 161:952-6.
76. Kawashima H, Li YF, Watanabe N, et al. Identification and characterization of ligands for L-selectin in the kidney. I. Versican, a large chondroitin sulfate proteoglycan, is a ligand for L-selectin. Int Immunol 1999; 11:393-405.
77. Johnson PR. Role of human airway smooth muscle in altered extracellular matrix production in asthma. Clin Exp Pharmacol Physiol 2001; 28:233-6.
78. Bensadoun ES, Burke AK, Hogg JC, et al. Proteoglycan deposition in pulmonary fibrosis. Am J Respir Crit Care Med 1996; 154:1819-28.
79. Borland G, Ross JA, Guy K. Forms and functions of CD44. Immunology 1998; 93:139-48.
80. Aruffo A, Stamenkovic I, Melnick M, et al. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61:1303-13.
81. Yu Q, Toole BP, Stamenkovic I. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J Exp Med 1997; 186:1985-96.
82. Vink J, Thomas L, Etoh T, et al. Role of beta-1 integrins in organ specific adhesion of melanoma cells in vitro. Lab Invest 1993; 68:192-203.
83. Lesley J, Howes N, Perschl A, et al. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J Exp Med 1994; 180:383-7.
84. Gunthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65:13-24.
85. Sy MS, Quo YJ, Stamenkovic I. Distinct effects of two CD44 in vivo. J Exp Med 1991; 174:859-66.
86. Hua Q, Knudson CB, Knudson W. Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. J Cell Sci 1993; 106(Pt 1):365-75.
87. Varner JA, Cheresh DA. Integrins and cancer. Curr Opin Cell Biol 1996; 8:724-30.
88. Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999; 285:1028-32.
89. Denda S, Reichardt LF, Muller U. Identification of osteopontin as a novel ligand for the integrin alpha8 beta1 and potential roles for this integrin-ligand interaction in kidney morphogenesis. Mol Biol Cell 1998; 9:1425-35.
90. Brandenberger R, Schmidt A, Linton J, et al. Identification and characterization of a novel extracellular matrix protein nephronectin that is associated with integrin alpha8beta1 in the embryonic kidney. J Cell Biol 2001; 154:447-58.
91. Yokosaki Y, Matsuura N, Higashiyama S, et al. Identification of the ligand binding site for the integrin alpha9 beta1 in the third fibronectin type III repeat of tenascin-C. J Biol Chem 1998; 273:11423-8.
92. Wu Y, Chen L, Zheng PS, et al. beta 1-Integrin-mediated glioma cell adhesion and free radical-induced apoptosis are regulated by binding to a C-terminal domain of PG-M/versican. J Biol Chem 2002; 277:12294-301.
93. Yamada KM, Even-Ram S. Integrin regulation of growth factor receptors. Nat Cell Biol 2002; 4:E75-6.
94. Schwartz MA, Assoian RK. Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. J Cell Sci 2001; 114:2553-60.
95. Frisch SM, Screaton RA. Anoikis mechanisms. Curr Opin Cell Biol 2001; 13:555-62.
96. Lu Z, Jiang G, Blume-Jensen P, et al. Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol Cell Biol 2001; 21:4016-31.
97. Wu Y, Chen L, Cao L, Sheng W, Yang BB. Overexpression of the C-terminal PG-M/versican domain impairs growth of tumor cells by intervening in the interaction between epidermal growth factor receptor and betal-integrin. J Cell Sci 2004; 117:2227-37.
98. Wu Y, Sheng W, Chen L, et al. Versican V1 isoform induces neuronal differentiation and promotes neurite outgrowth. Mol Biol Cell 2004; 15:2093-104.
99. Pouyani T, Seed B. PSGL-1 recognition of P-selectin is controlled by a tyrosine sulfation consensus at the PSGL-1 amino terminus. Cell 1995; 83:333-43.
100. Sako D, Chang XJ, Barone KM, et al. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 1993; 75:1179-86.
101. Moore KL, Patel KD, Bruehl RE, et al. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol 1995; 128:661-71.
102. Leppanen A, Penttila L, Renkonen O, et al. Glycosulfopeptides with O-glycans containing sialylated and polyfucosylated polylactosamine bind with low affinity to P-selectin. J Biol Chem 2002; 277:39749-59.
103. Zheng PS, Vais D, Lapierre D, et al. PG-M/versican binds to P-selectin glycoprotein ligand-1 and mediates leukocyte aggregation. J Cell Sci 2004; 117:5887-95.
104. Olsson U, Camejo G, Hurt-Camejo E, et al. Possible functional interactions of apolipoprotein B-100 segments that associate with cell proteoglycans and the ApoB/E receptor. Arterioscler Thromb Vasc Biol 1997; 17:149-55.
105. Olin KL, Potter-Perigo S, Barrett PH, et al. Lipoprotein lipase enhances the binding of native and oxidized low density lipoproteins to versican and biglycan synthesized by cultured arterial smooth muscle cells. J Biol Chem 1999; 274:34629-36.
106. Srinivasan SR, Xu JH, Vijayagopal P, et al. Low-density lipoprotein binding affinity of arterial chondroitin sulfate proteoglycan variants modulates cholesteryl ester accumulation in macrophages. Biochim Biophys Acta 1995; 1272:61-7.